EP1158956A1 - Ölbäder - Google Patents

Ölbäder

Info

Publication number
EP1158956A1
EP1158956A1 EP00922492A EP00922492A EP1158956A1 EP 1158956 A1 EP1158956 A1 EP 1158956A1 EP 00922492 A EP00922492 A EP 00922492A EP 00922492 A EP00922492 A EP 00922492A EP 1158956 A1 EP1158956 A1 EP 1158956A1
Authority
EP
European Patent Office
Prior art keywords
acid
carbon atoms
alkyl
esters
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00922492A
Other languages
German (de)
English (en)
French (fr)
Inventor
Werner Seipel
Celia Kosboth
Norbert Boyxen
Josef Koester
Hermann Hensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis IP Management GmbH
Original Assignee
Cognis Deutschland GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Deutschland GmbH and Co KG filed Critical Cognis Deutschland GmbH and Co KG
Publication of EP1158956A1 publication Critical patent/EP1158956A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin

Definitions

  • the invention relates to clear, alkanolamide and water-free cosmetic preparations for use in skin and hair care with a defined content of a mixture of fatty alcohol (polyglycol) ester, fatty alcohol polyglycol ethers, polyols, alkyl and / or alkylene oligoglycosides and oil bodies.
  • tensides and oils can be mixed in any ratio depending on the desired application.
  • These formulations previously contained alkanolamides, which belong to the "nitrosamine-forming substances". Nitrosamines in any small amount, not because of their presence in cosmetics, but if they get into the body, have a harmful effect. For this reason, cosmetic preparations which are not Alkanolamides contain, desirable, however, the removal of alkanolamides from the surfactant mixtures leads to cloudy formulations when mixed with oil components.
  • the object of the present invention was therefore to provide clear, water-free cosmetic preparations by mixing alkanolamide-free surfactant mixtures with defined amounts of oil bodies, which do not show any cloudiness even when stored.
  • the invention relates to cosmetic preparations free from alkanolamides, consisting of
  • anhydrous cosmetic preparations can be prepared from cloudy, alkanolamide-free surfactant mixtures consisting of fatty acid (polyglycol) esters, fatty alcohol polyglycol ethers, polyols, alkyl and / or alkylene oligoglycosides by adding a defined amount of oil body. These are also characterized by good regreasing, good foam properties and storage stability.
  • the agents according to the invention can contain fatty acid (polyglycol) esters, which form component (a1), of the formula (I)
  • R 1 CO represents a linear or branched, saturated or unsaturated acyl radical having 6 to 30, preferably 8 to 22 and in particular 10 to 18 carbon atoms
  • x is an average of 0 to 30, preferably 5 to 20 and in particular 10 to 15 and AO for a CH 2 CH 2 O, CH 2 CH (CH 3 ) 0 and / or CH (CH 3 ) CH 2 O radical
  • R 2 for a linear or branched, saturated or unsaturated alkyl radical with 1 to 4 and preferably 1 and / or 2 Carbon atoms and especially methyl is produced by esterification of the corresponding fatty acid (polyglycols).
  • ethylene oxide, propylene oxide or a mixture thereof - in random or block distribution - is optionally added to the corresponding fatty acids, this reaction being acid-catalyzed, but preferably in the presence of bases, such as, for example, nathummethylate or calcined hydrotalcite.
  • Typical examples of suitable starting materials are the addition products of 10 to 15 moles of ethylene oxide and / or propylene oxide, but preferably the adducts with 12 moles of ethylene oxide or 12 moles of propylene oxide with caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, Palmoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures, which are then esterified.
  • the fatty acid (polyglycol) esters can be used in amounts of 0.1 to 20, preferably 0.5 to 10 and in particular 1 to 5% by weight, in each case based on the keratin-reducing substance or the oxidizing agent .
  • Fatty alcohol polyglycol ethers which form component (a2), are to be understood as primary aliphatic polyglycol ethers of the formula (II)
  • R 3 is a linear or branched, saturated or unsaturated hydrocarbon radical having 10 to 18 carbon atoms and m is an average of 2 to 6 numbers.
  • Typical examples are addition products of an average of 2 to 6 moles of ethylene oxide with lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, and high pressure dermaling, for example in the case of technical high pressure dermaling and elaeostearylation, and their elective mixtures technical methyl esters based on fats and oils or aldehydes from Roelen's oxosynthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols.
  • Polyols which form component (a3) preferably have 2 to 15 carbon atoms and at least two hydroxyl groups.
  • the polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are
  • Alkylene glycols such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons;
  • Methyl compounds such as in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Lower alkyl glucosides in particular those with 1 to 8 carbons in the alkyl radical, such as methyl and butyl glucoside;
  • Sugar alcohols with 5 to 12 carbon atoms such as sorbitol or mannitol,
  • Aminosugars such as glucamine
  • Dialcohol amines such as diethanolamine or 2-amino-1, 3-propanediol.
  • Glycerol, butylene glycol, hexylene glycol, polyethylene glycols and in particular propylene glycol with an average molecular weight in the range from 100 to 1,000 daltons are preferably used.
  • the agents according to the invention can contain components (a) in amounts of 30 to 70, preferably 40 to 60 and in particular 50% by weight.
  • the compositions comprise a mixture of (a1) fatty acid ⁇ polyglycol) esters, preferably 45% by weight, (a2) fatty alcohol polyglycol ethers, preferably 45% by weight and (a3) polyols, preferably in particular 10% by weight .-%.
  • Alkyl and / or alkenyl oligoglycosides which form component (a4) are known nonionic surfactants which follow the formula (III)
  • R 4 is an alkyl and / or alkenyl radical having 4 to 22 carbon atoms
  • G is a sugar radical having 5 or 6 carbon atoms
  • p is a number from 1 to 10.
  • the alkyl and / or alkenyl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
  • the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucosides.
  • the index number p in the general formula (III) indicates the degree of oligomerization (DP), ie the distribution of mono- and oligoglycosides, and stands for a number between 1 and 10.
  • Alkyl and / or alkenyl oligoglycosides with an average degree of oligomerization p of 1.1 to 3.0 are preferably used. From an application point of view, those alkyl and / or alkenyl oligoglycosides are preferred whose degree of oligomerization is less than 1.7 and is in particular between 1.2 and 1.4.
  • the alkyl or alkenyl radical R 4 can be derived from primary alcohols having 4 to 11, preferably 8 to 10, carbon atoms. Typical examples are butanol, capronic alcohol, caprylic alcohol, capric alcohol and undecyl alcohol and their technical mixtures, such as, for example can be obtained from the hydrogenation of technical methyl esters or, reportedly, from the hydrogenation of aldehydes from Roelen's oxosynthesis.
  • the alkyl or alkenyl radical R 3 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14, carbon atoms.
  • Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol and their technical mixtures, which can be obtained as described above.
  • Alkyl oligoglucosides based on hardened C 1/2 coco alcohol with a DP of 1 to 3 are preferred.
  • oil bodies which form component (b) are Guerbet alcohols based on fatty alcohols having 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C6-C22 fatty acids with linear C6-C22 fatty alcohols, esters of branched C6- C ⁇ 3 carboxylic acids with linear C6-C22 fatty alcohols, esters of linear C6-C22 fatty acids with branched alcohols, especially 2-ethylhexanol, esters of hydroxycarboxylic acids with linear or branched C6-C22 fatty alcohols, especially dioctyl malates, esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on C6-C ⁇ o fatty acids, liquid mono- / di- / triglyceride mixtures based on C ⁇ -Cis fatty acids
  • the cosmetic preparations according to the invention can be used for the production of clear, alkanolamine-free hair and skin care products.
  • the agents such as, for example, hair shampoos, hair lotions, foam baths, shower baths, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions or emulsions, can furthermore contain, as further auxiliaries and additives, mild surfactants, emulsifiers, superfatting agents, pearlescent waxes, consistency agents, thickeners, polymers , Silicone compounds, fats, waxes, stabilizers, biogenic active ingredients, deodorant active ingredients, anti-dandruff agents, film formers, swelling agents, UV light protection factors, antioxidants, preservatives, insect repellents, self-tanners, solubilizers, perfume oils, dyes, germ-inhibiting agents and the like.
  • Suitable mild, i.e. Particularly skin-compatible surfactants are monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid retaurides, fatty acid glutamates, ether carboxylic acids, ⁇ -olefin sulfonates, fatty acid glucamides, alkylamido betaine and / or protein fatty acid condensates, preferably based on protein fatty acids.
  • Suitable emulsifiers are nonionic surfactants from at least one of the following groups:
  • polyol and especially polyglycerol esters such as e.g. Polyglycerol polyricinoleate, polyglycerol poly-12-hydroxystearate or polyglycerol dimer isostearate. Mixtures of compounds from several of these classes of substances are also suitable;
  • partial esters based on linear, branched, unsaturated or saturated C6 / 22 fatty acids, ricinoleic acid as well as 12-hydroxystearic acid and glycerin, polyglycerin, pentaerythritol, dipentaerythritol, sugar alcohols (e.g. sorbitol), alkyl glucosides (e.g. methyl glucoside, butyl glucoside, butyl glucoside, - coside) and polyglucosides (eg cellulose);
  • adducts of ethylene oxide and / or of propylene oxide with fatty acids, alkylphenols, glycerol mono- and diesters as well as sorbitan mono- and diesters with fatty acids or with castor oil are known, commercially available products. These are homolog mixtures whose average degree of alkoxylation is equivalent to that Ratio of the amounts of ethylene oxide and / or propylene oxide and substrate with which the addition reaction is carried out corresponds.
  • Ci2 / ⁇ fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE 2024051 PS as refatting agents for cosmetic preparations.
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N, N-dimethylammonium glycinate, for example coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example coconut acylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxylm -hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, in addition to a C ⁇ / i ⁇ -alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SOaH group in the molecule and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and Ci2 / i8-acylsarcosine.
  • quaternary emulsifiers are also suitable, those of the ester quat type, preferably methyl-quaternized difertetic acid, triethanolamine ester salts, being particularly preferred.
  • Substances such as, for example, lanolin and lecithin as well as polyethylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid realkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • Pearlescent waxes are: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15 carbon atoms
  • Suitable consistency agents are primarily fatty alcohols or hydroxyfatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, Aerolsil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates , (eg Carbopole® from Goodrich or Synthalene® from Sigma), polyacrylamides, polyvinyl alcohol and polyvinylpyrrolidone, surfactants such as ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as pentaerythritol or trimethyloipropan, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides Cooking salt and ammonium chloride.
  • Aerolsil types hydrophilic silicas
  • polysaccharides in particular
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, such as, for example, a quaternized hydroxyethyl cellulose, which is available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers, such as, for example, Luviquat® (BASF) , Condensation products of polyglycols and amines, quaternized collagen polypeptides, such as, for example, lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, such as, for example, amidomethicones, copolymers of adipic acid and dimethyldiethylaminohydroxypropylaminohydroxyaminohydroxyaminohydroxin
  • Suitable anionic, zwitterionic, amphoteric and nonionic polymers are, for example, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and esters thereof, uncrosslinked and polyol-crosslinked polyacrylic acids, acrylamidopropyl / Acrylate copolymers, octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate / 2-hydroxyproyl methacrylate copolymers, polyvinyl pyrrolidone, vinyl pyrrolidone / vinyl acetate copolymers, vinyl pyrrolidone / dimethylaminoethyl methacrylate / vinyl caprolactam terpolymers and
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and / or alkyl-modified silicone compounds, which can be both liquid and resinous at room temperature.
  • suitable volatile silicones can also be found by Todd et al. in Cosm.Toil. 91, 27 (1976).
  • Typical examples of fats are glycerides, waxes include Beeswax, carnauba wax, candelilla wax, montan wax, paraffin wax, hydrogenated castor oils, fatty acid esters or micro waxes solid at room temperature, optionally in combination with hydrophilic waxes, e.g. Cetyl stearyl alcohol or partial glycerides in question.
  • Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate are used.
  • Biogenic active substances are, for example, tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, deoxyribonucleic acid, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils, plant extracts and vitamin complexes.
  • Antiperspirants such as aluminum chlorohydates are suitable as deodorant active ingredients. These are colorless, hygroscopic crystals that easily dissolve in the air and arise when aqueous aluminum chloride solutions are evaporated.
  • Aluminum chlorohydrate is used to manufacture antiperspirant and deodorant preparations and is likely to act by partially occluding the sweat glands through protein and / or polysaccharide precipitation [cf. J. Soc. Cosm.Chem. 24, 281 (1973)].
  • esterase inhibitors can be added as further deodorant active ingredients. These are preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT, Henkel KGaA, Düsseldorf / FRG). The substances inhibit enzyme activity and thereby reduce odor. The cleavage of the citric acid ester probably releases the free acid, which lowers the pH value on the skin to such an extent that the enzymes are inhibited.
  • trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT, Henkel KGaA, Düsseldorf / FRG).
  • the substances inhibit enzyme activity and thereby reduce odor.
  • the cleavage of the citric acid ester probably releases the free acid, which lowers the pH value on
  • esterase inhibitors include sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campesteric, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, such as, for example, glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, adipic acid, Monoethyl adipate, diethyl adipate, malonic and diethyl malonate, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or tartaric acid diethyl ester.
  • dicarboxylic acids and their esters such as, for example, glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, adipic acid, Monoethyl adipate, diethyl adipate, malonic and diethyl malonate
  • Antibacterial agents that influence the bacterial flora and kill sweat-killing bacteria or inhibit their growth can also be contained in the stick preparations.
  • Examples include chitosan, phenoxyethanol and chlorhexidine gluconate.
  • 5-Chloro-2- (2,4-dichlorophen-oxy) phenol which is sold under the Irgasan® brand by Ciba-Geigy, Basel / CH, has also proven to be particularly effective.
  • Climbazole, octopirox and zinc pyrethione can be used as antidandruff agents.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Montmorillonites, clay minerals, pemules and alkyl-modified carbopol types can serve as swelling agents for aqueous phases. Further suitable polymers or swelling agents can be found in the overview by R. Lochhead in Cosm.Toil. 108, 95 (1993).
  • UV light protection factors are understood to mean, for example, organic substances (light protection filters) which are liquid or crystalline at room temperature and which are able to absorb ultraviolet rays and absorb the energy absorbed in the form of longer-wave radiation, e.g. To give off heat again.
  • UVB filters can be oil-soluble or water-soluble. As oil-soluble substances e.g. to call:
  • 3-benzylidene camphor or 3-benzylidene norcampher and its derivatives e.g. 3- (4-methylbenzylidene) camphor as described in EP 0693471 B1;
  • 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and amyl 4- (dimethylamino) benzoate; • esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate, propyl 4-methoxycinnamate, 2-cyano-3,3-phenylcinnamate 2-ethylhexyl 4-methoxycinnamate (octocrylene);
  • esters of salicylic acid preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomethyl salicylic acid;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate
  • Triazine derivatives e.g. 2,4,6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine and octyl triazone, as described in EP 0818450 A1;
  • Propane-1,3-dione e.g. 1- (4-tert-butylphenyl) -3- (4'methoxyphenyl) propane-1,3-dione;
  • Sulfonic acid derivatives of 3-benzylidene camphor e.g. 4- (2-oxo-3-bornylidene methyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) sulfonic acid and their salts.
  • UV-A filters -4'-methoxydibenzoyl-methane (Parsol 1789), or 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione.
  • the UV-A and UV-B filters can of course also be used in mixtures.
  • insoluble light protection pigments namely finely dispersed metal oxides or salts, are also suitable for this purpose.
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof.
  • Silicates (talc), barium sulfate or zinc stearate can be used as salts.
  • the oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics.
  • the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They can have a spherical shape, but it is also possible to use particles which have an ellipsoidal shape or shape which differs from the spherical shape in some other way. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used. Further suitable UV light protection filters can be found in the overview by P. Finkel in SOFW Journal 122, 543 (1996).
  • secondary light stabilizers of the antioxidant type can also be used, which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin.
  • Typical examples are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine) , Carotenoids, carotenes (e.g.
  • ⁇ -carotene, ß-carotene, lycopene) and their derivatives chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (e.g.
  • thioredoxin glutathione, cysteine, Cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyithiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthioninsulfoximines, homocysteine sulfoximine, butioninsulfones, penta-, hexa-, himinathioninsulfoxins ) in very low tolerable doses (e.g.
  • ⁇ -hydroxy fatty acids e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • bile acid bile extracts
  • bilirubin biliverdin
  • EDTA EDTA
  • EGTA unsaturated fatty acids and their derivatives
  • unsaturated fatty acids and their derivatives eg ⁇ -linolenic acid, linoleic acid, oleic acid
  • folic acid and their derivatives ubiquinone and ubiquinol and their derivatives
  • vitamin C and derivatives eg ascorbyl palmitate, Mg-ascorbyl phosphate, ascorbyl acetate
  • Tocopherols and derivatives e.g.
  • vitamin E acetate
  • vitamin A and derivatives vitamin A palmitate
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.
  • N, N-diethyl-m-touluamide, 1, 2-pentanediol or 3535 insect repellants are suitable as insect repellents, and dihydroxyacetone is suitable as a self-tanning agent.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway seeds, juniper), fruit peel (bergamot, lemon, oranges), root (Meuse, Angeiica, Beiene, Kar ⁇ amon, uostus, ins, Calmus), woods (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass , Sage, thyme), needles and twigs (spruce, fir, pine, mountain pine), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethyl methylphenylglycinate, allylcyclohexyl benzylatepylpropionate, allyl cyclohexyl propyl pionate.
  • the ethers include, for example, benzyl ethyl ether
  • the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal
  • the ketones include, for example, the jonones, c-isomethylionone and methylcedryl ketone the alcohols anethol, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol
  • the hydrocarbons mainly include the terpenes and balsams.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, for example sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • bergamot oil dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, ⁇ -hexylcinnamaldehyde, geraniol, benzyl acetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, Sandelice, lemon oil, mandarin oil, orange oil, allyl amyl glycolate, Cyclovertal, lavandin oil, muscatel Sage oil, ß-damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilllate, irot
  • the dyes which can be used are those substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • germ-inhibiting agents are preservatives with a specific action against gram-positive bacteria, such as, for example, 2,4,4'-trichloro-2'-hydroxydiphenyl ether, chlorhexidine (1,6-di- (4-chlorophenyl-biguanido) hexane) or TCC (3,4,4'-trichlorocarbanilide).
  • gram-positive bacteria such as, for example, 2,4,4'-trichloro-2'-hydroxydiphenyl ether, chlorhexidine (1,6-di- (4-chlorophenyl-biguanido) hexane) or TCC (3,4,4'-trichlorocarbanilide).
  • Numerous fragrances and essential oils also have antimicrobial properties.
  • Typical examples are the active ingredients eugenol, menthol and thymol in clove, mint and thyme oil.
  • terpene alcohol farnesol (3,7,1 1 -trimethyl-2,6, 10-dodecatrien-1 -ol)
  • Glycerol monolaurate has also proven itself as a bacteriostatic.
  • the proportion of the additional germ-inhibiting agents is usually about 0.1 to 2% by weight, based on the solids content of the preparations.
  • the total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition.
  • the agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
  • the alkanolamide-free surfactant formulation (a) was used to produce oil baths.
  • the surfactant oil ratio and the results are summarized in Table 1.
  • the oil baths with the surfactant formulation (a) are characterized by good foam properties and good regreasing.
  • Oil baths Composition in% by weight

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
EP00922492A 1999-03-10 2000-03-02 Ölbäder Withdrawn EP1158956A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19910704 1999-03-10
DE1999110704 DE19910704B4 (de) 1999-03-10 1999-03-10 Kosmetische Zubereitungen und deren Verwendung
PCT/EP2000/001814 WO2000053156A1 (de) 1999-03-10 2000-03-02 Ölbäder

Publications (1)

Publication Number Publication Date
EP1158956A1 true EP1158956A1 (de) 2001-12-05

Family

ID=7900498

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00922492A Withdrawn EP1158956A1 (de) 1999-03-10 2000-03-02 Ölbäder

Country Status (4)

Country Link
EP (1) EP1158956A1 (ja)
JP (1) JP2002538193A (ja)
DE (1) DE19910704B4 (ja)
WO (1) WO2000053156A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9687425B2 (en) 2014-06-30 2017-06-27 The Procter & Gamble Company Personal care compositions and methods
US9717930B2 (en) 2013-03-12 2017-08-01 The Procter & Gamble Company Antiperspirant compositions
US9877909B2 (en) 2014-06-30 2018-01-30 The Procter & Gamble Company Personal care compositions and methods
US10016343B2 (en) 2013-03-12 2018-07-10 The Procter & Gamble Company Solid stick antiperspirant compositions

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19927168A1 (de) * 1999-06-15 2000-12-21 Cognis Deutschland Gmbh Ölbäder
JP4757446B2 (ja) * 2004-01-09 2011-08-24 株式会社 資生堂 油性クレンジング組成物
DE102007006778A1 (de) * 2007-02-08 2008-08-14 Beiersdorf Ag Neues Duschöl
MX368365B (es) 2009-12-22 2019-09-30 Avon Prod Inc Composiciones estimuladoras de paxilina y usos cosmeticos de las mismas.
EP2588593B1 (en) 2010-06-30 2017-08-23 Avon Products, Inc. Compositions and methods for stimulating magp-1 to improve the appearance of skin
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
FR2983407B1 (fr) * 2011-12-06 2014-01-03 Oreal Composition aqueuse riche en huile et son utilisation dans un procede de coloration d'oxydation ou de decoloration
TW201422250A (zh) * 2012-12-11 2014-06-16 Avon Prod Inc Ｎｅｓｐｒｉｎ－２表現調節劑之用途及其組合物
US20150161528A1 (en) * 2013-12-09 2015-06-11 Amadeus S.A.S. Automated detection of travel incidents and rebooking of travel itineraries impacted by same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424849A (en) * 1965-07-13 1969-01-28 Procter & Gamble Bath oil composition containing octyl dodecanoate
DE3724547A1 (de) * 1987-07-24 1989-02-02 Henkel Kgaa Alkanolamidfreies perlglanzkonzentrat
US5455025A (en) * 1992-04-02 1995-10-03 Croda, Inc. Non-aqueous emollient compositions for topical application
ES2081657T3 (es) * 1992-05-13 1996-03-16 Hoechst Ag Dispersiones nacaradas no ionicas, de buena fluidez.
DE4326112A1 (de) * 1993-08-04 1995-02-09 Henkel Kgaa Reinigungsmittel für harte Oberflächen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0053156A1 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717930B2 (en) 2013-03-12 2017-08-01 The Procter & Gamble Company Antiperspirant compositions
US9937113B2 (en) 2013-03-12 2018-04-10 The Procter & Gamble Company Antiperspirant compositions
US10016343B2 (en) 2013-03-12 2018-07-10 The Procter & Gamble Company Solid stick antiperspirant compositions
US10052271B2 (en) 2013-03-12 2018-08-21 The Procter & Gamble Company Antiperspirant compositions
US9687425B2 (en) 2014-06-30 2017-06-27 The Procter & Gamble Company Personal care compositions and methods
US9750671B2 (en) 2014-06-30 2017-09-05 The Procter & Gamble Company Personal care compositions and methods
US9877909B2 (en) 2014-06-30 2018-01-30 The Procter & Gamble Company Personal care compositions and methods
US10154949B2 (en) 2014-06-30 2018-12-18 The Procter & Gamble Company Personal care compositions and methods
US10413493B2 (en) 2014-06-30 2019-09-17 The Procter & Gamble Company Personal care composition and methods
US10716743B2 (en) 2014-06-30 2020-07-21 The Procter & Gamble Company Personal care compositions and methods

Also Published As

Publication number Publication date
WO2000053156A1 (de) 2000-09-14
JP2002538193A (ja) 2002-11-12
DE19910704B4 (de) 2006-04-20
DE19910704A1 (de) 2000-09-14

Similar Documents

Publication Publication Date Title
WO1999051199A1 (de) Verfahren zur herstellung von kosmetischen reinigungsmitteln mit erhöhter viskosität
WO2000033794A2 (de) Ölbäder
DE19910704B4 (de) Kosmetische Zubereitungen und deren Verwendung
WO2000066075A1 (de) Sonnenschutzmittel
WO2000027343A2 (de) Kosmetische und/oder pharmazeutische zubereitungen die esterquats und partialglyceride enthalten
DE19916208B4 (de) Sonnenschutzmittel
EP1162941A2 (de) Sonnenschutzmittel
DE19828020B4 (de) Verwendung von Mischungen, enthaltend lineare Fettalkohole, 12-Hydroxystearinsäure, Fettketone und/oder Fettether als Verdickungsmittel für kosmetische Zubereitungen in Stiftform
DE19825462C2 (de) Emulgatoren
EP0980683A1 (de) Verfahren zur Herstellung von stabilen Emulsionen
WO1999066898A1 (de) Verwendung von dialkylcarbonaten zur herstellung von abschminkmitteln
WO2001037798A1 (de) Sonnenschutzmittel
DE19917745A1 (de) Milde wäßrige Zubereitungen
EP1131049B1 (de) Verwendung von kationaktiven mischungen
DE19916209C2 (de) Kosmetische Zubereitungen
EP1128808B1 (de) Verwendung von kationaktiven mischungen
EP1171096B1 (de) Kosmetische zubereitungen
EP0992489B1 (de) Betaine
WO1999009935A2 (de) Kosmetische zubereitungen enthaltend fettsäurepolyglycolestersulfate und polymere
WO2001037791A2 (de) Verwendung von alkyl- und/oder alkenyloligoglykosid-fettsäureestern als pigmentdispergator
EP1048283A1 (de) Verwendung von Mischungen aus Oligoglykosiden, Polyolpoly-12-hydroxystearaten und Ölkörpern zur Herstellung von Abschminkmitteln
WO2000076459A2 (de) Alkanolamid- und wasserfreie ölbäder
WO2001037790A1 (de) Verwendung von alkyl- und/oder alkenyloligoglykosid-fettsäureestern zur verbesserung der sensorischen beurteilung von emulsionen
DE19829787A1 (de) Avivagemittel
DE19830374A1 (de) Kosmetische Zubereitungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010903

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COGNIS DEUTSCHLAND GMBH & CO. KG

RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT

17Q First examination report despatched

Effective date: 20041116

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COGNIS IP MANAGEMENT GMBH

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051001